Barclays Maintains Overweight on Ovintiv, Raises Price Target to $62

Benzinga Newsdesk www.benzinga.com Positive 80.6%

Neg 0% Neu 0% Pos 80.6%

Barclays analyst Betty Jiang maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $58 to $62.